Raltegravir 400mg
Raltegravir 400 mg is an antiretroviral formulation indicated for the management of HIV-1 infection. In accordance with WHO and NACO treatment guidelines, it is administered as a component of combination antiretroviral therapy (ART) to effectively suppress viral replication.
Product Details
Therapeutic Class
HIV Integrase Strand Transfer Inhibitor (INSTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
400 mg twice daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 tablets
Raltegravir 400mg
Raltegravir 400 mg is an antiretroviral formulation indicated for the management of HIV-1 infection. In accordance with WHO and NACO treatment guidelines, it is administered as a component of combination antiretroviral therapy (ART) to effectively suppress viral replication.
Product Details
Therapeutic Class
HIV Integrase Strand Transfer Inhibitor (INSTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
400 mg twice daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 tablets
Raltegravir 400mg
Raltegravir 400 mg is an antiretroviral formulation indicated for the management of HIV-1 infection. In accordance with WHO and NACO treatment guidelines, it is administered as a component of combination antiretroviral therapy (ART) to effectively suppress viral replication.
Product Details
Therapeutic Class
HIV Integrase Strand Transfer Inhibitor (INSTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
400 mg twice daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 tablets